Join Clinical Trials in Colorado Springs, Colorado

Browse Locations United States » Colorado » Colorado Springs

Study of a Cold Sore Patch for the Treatment of Herpes Labialis

Condition: Herpes Labialis
Intervention: Device: Patch ( Compeed© Total CareTM Cold Sore Patch)
Sponsors: Johnson & Johnson Consumer and Personal Products Worldwide; Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc.
Completed - verified April 2012
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)

Condition: Herpes Zoster
Interventions: Biological: V212; Biological: Placebo
Sponsors: Merck; Merck
Recruiting - verified May 2012
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (Study No. V212-001 AM3)

Condition: Herpes Zoster
Interventions: Biological: V212; Biological: Matching placebo
Sponsors: Merck; Merck
Recruiting - verified May 2012
Study to Evaluate Using a Cold Sore Patch to Treat Herpes Labialis

Condition: Herpes Labialis
Intervention: Device: Cold Sore Patch
Sponsors: Johnson & Johnson Consumer and Personal Products Worldwide; Johnson & Johnson Consumer and Personal Products Worldwide
Completed - verified October 2011
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 70 Years

Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster Vaccine GSK1437173A; Biological: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified April 2012
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 50 Years

Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster Vaccine GSK1437173A; Biological: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified April 2012
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects

Condition: Herpes Zoster in HIV-infected Subjects
Interventions: Biological: Herpes Zoster Vaccine 1437173A; Biological: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified February 2012
A Comparative Study of the Efficacy of Penciclovir 10mg/g (1%) Cream in Preventing the Appearance of Classical Lesion in Recurrent Cold Sore Sufferers

Condition: Cold Sore
Interventions: Drug: Penciclovir; Drug: Placebo
Sponsors: Novartis; Novartis
Completed - verified December 2010
Efficacy, Safety and Tolerability Study of TAK-583 in Subjects With Postherpetic Neuralgia

Condition: Neuralgia, Postherpetic
Interventions: Drug: TAK-583; Drug: TAK-583; Drug: TAK-583; Drug: TAK-583; Drug: Placebo
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Center, Inc.
Completed - verified January 2012
Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old

Condition: Herpes Simplex
Interventions: Biological: GSK208141; Biological: HavrixTM (investigational formulation); Biological: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified April 2012